SH PHARMA announced that its holding subsidiary, Shanghai Sh pharma Xinya Pharmaceutical Co., Ltd., received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration regarding injectable Cefoperazone Sodium, and this product has passed the consistency evaluation for generic drugs. Injectable Cefoperazone Sodium is primarily used for lower respiratory tract infections, urinary tract infections, abdominal infections, pelvic infections, sepsis, skin and soft tissue infections, bone and joint infections, meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, and uncomplicated gonorrhea caused by sensitive bacteria. In September 2023, Sh pharma Xinya applied for and received acceptance from the National Medical Products Administration for the consistency evaluation of this drug. As of the date of this announcement, the company has invested approximately 5 million yuan in research and development expenses for the consistency evaluation of this drug. In 2024, the procurement amount for this injectable drug in hospitals is 3,608.77 million yuan.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
Howard Marks' latest discussion talks about the importance of luck and how to make oneself luckier.
Meituan's Q4 revenue reached 88.487 billion yuan, a year-on-year increase of 20.1%, and losses in new Business have significantly narrowed.
Musk: The production of Optimus Siasun Robot&Automation has been realized at the Fremont factory, with a production target of 5,000 units this year.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
上海医药:注射用头孢唑肟钠通过仿制药一致性评价
SH PHARMA: The injectable Cefoperazone Sodium has passed the consistency evaluation for generic drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 303
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report